Medicine (Predictive, Personalized, Preventive, Participating, and Precise, Evidence-Based) for the Management of NAFDL, NASH, Fibrosis, Compensated Cirrhosis, Liver Cancer, HCC Risk and Prognosis, is well established…
incidences of end-stage liver disease and hepatocellular carcinoma arising from nonalcoholic steatohepatitis (NASH) are rapidly increasing. Although weight reduction is recommended as an initial treatment, no…
number of patients in Non-alcoholic Steatohepatitis (NASH) and its associated Hepato Cellular Carcinoma (HCC) is increasing rapidly along with the change of lifestyle. So far, however, no diagnostic tools…
international traders and investors. This study adopts nonlinear grey Bernoulli model (NGBM) and Nash NGBM (NNGBM) to predict the currency exchange rate of Taiwan’s two top trading partners, America
center has seen an increase in the proportion of non-alcoholic steatohepatitis(NASH)-related liver cirrhosis transplant recipients compared to patients with etiological causes. This implies an increase ... incidence of…
Medicine (Predictive, Personalized, Preventive, Participating, and Precise, Evidence-Based) for the Management of NAFDL, NASH, Fibrosis, Compensated Cirrhosis, Liver Cancer, HCC Risk and Prognosis, is well established…
target the liver parenchyma (AIH) or the bile ducts (PSC); and non- alcoholic steatohepatitis (NASH) which associates with abnormal lipid metabolism and fat deposition in the liver. An aggressive ... associated…
Reactive oxygen species (ROS) plays a key role in non-alcoholic steatohepatitis (NASH). Inactivation of glutathione peroxidase-4 (GPX4) induces ferroptosis, which is an iron dependent and lipid peroxidation-mediated…
pathogenesis of several chronic liver diseases, including nonalcoholic fatty liver disease (NAFLD). Nonalcoholic steatohepatitis (NASH), more severe stage of NAFLD, is characterized by steatosis, hepatocellular…
world. Although there is now effective therapy for Hepatitis C, fatty liver (NAFLD/NASH) has no recognized medical therapy other than weight loss. However, Metformin and PPAR gamma agonist have ... pathway and then…
Introduction: The global “obesity epidemic” has thrust nonalcoholic steatohepatitis (NASH) and the metabolic syndrometo the forefront of health-related concerns, and both are linked to the rising incidence of…
drug is also effective in the treatment of non-alcoholic steatohepatitis, NASH [3-5]. The two disparate findings might be reconciled by an effect of OCA on hepatic artery flow
Objective: Patients with nonalcoholic steatohepatitis (NASH) are at risk for developing cirrhosis and hepatic cancer. Currently, the definitive gold-standard method of diagnosing NASH is a liver biopsy, an invasive…
Usheera (Vetiveria zizanioides Linn. Nash) possesses a great therapeutic value in the traditional Ayurvedic medicine and is widely distributed in India. Apart from the medicinal value, the culms are used
from patients with hepatitis-C virus (HCV) mediated liver fibrosis and non-alcoholic steatohepatitis (NASH). Various isotope labelling approaches like ICAT, iTRAQ and TMT have been used for protein discovery
evaluate the antihyperglycaemic activity of the ethanol extract of roots of Vetiveria zizanioides (L.) Nash, in alloxan induced diabetic rats. Alloxan monohydrate (150 mg/kg) was administered to Wister albino